Cargando…
Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
BACKGROUND: There is growing interest in glutamatergic agents as a treatment for depression, especially intranasal ketamine, which has become a hot topic in recent years. We aim to assess the efficacy and safety of intranasal ketamine in the treatment of major depressive disorder (MDD), especially t...
Autores principales: | An, Dongjiao, Wei, Changwei, Wang, Jing, Wu, Anshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204747/ https://www.ncbi.nlm.nih.gov/pubmed/34140915 http://dx.doi.org/10.3389/fpsyg.2021.648691 |
Ejemplares similares
-
Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study
por: Buonsenso, Danilo, et al.
Publicado: (2014) -
Intranasal adminsitration of oxytocin in postnatal depression: implications for psychodynamic psychotherapy from a randomized double-blind pilot study
por: Clarici, Andrea, et al.
Publicado: (2015) -
Ketamine Enhances Intranasal Dexmedetomidine-Induced Sedation in Children: A Randomized, Double-Blind Trial
por: Qian, Bin, et al.
Publicado: (2020) -
Efficacy of intranasal ketamine and midazolam for pediatric sedation: A double-blind, randomized clinical trial
por: Khoshrang, Hossein, et al.
Publicado: (2021) -
Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial
por: Vaishnavi, BD, et al.
Publicado: (2023)